Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action modulators |
Mechanism SMN2 modulators(Survival motor neuron protein modulators), Gene transference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Spinal Muscular Atrophy | Preclinical | Italy | - | |
Spinal Muscular Atrophy | Preclinical | Italy | - | |
Spinal Muscular Atrophy | Preclinical | Switzerland | - | |
Spinal Muscular Atrophy | Preclinical | Netherlands | - |